The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,056,370 in first-year total cost, median $605,070.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-U (M3)]3
- Special Emphasis Panel[ZCA1 RTRB-E (M1)]2
- Special Emphasis Panel[ZCA1 RTRB-E (O1)]2
- Special Emphasis Panel[ZCA1 RPRB-L (O2)]1
- Special Emphasis Panel[ZCA1 RTRB-Y (M1)]1
Most frequent institutions
- COLD SPRING HARBOR LABORATORY1
- FRED HUTCHINSON CANCER RESEARCH CENTER1
- JOHNS HOPKINS UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC1U01CA235625-01 | MACPHERSON, DAVID | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $516,606 | ZCA1 |
| 2019 | Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer1U01CA242919-01 | VAKOC, CHRISTOPHER | COLD SPRING HARBOR LABORATORY, NY | $439,200 | ZCA1 |
| 2018 | Using patient-derived models to understand drug responses in SCLC1U01CA220323-01A1 | DYSON, NICHOLAS JFARAGO, ANNA FLORA | MASSACHUSETTS GENERAL HOSPITAL, MA | $619,923 | ZCA1 |
| 2018 | Bioinformatic-Chemical Approach to Credential Molecular Targets to Combat Rapid Chemo-Radiation Resistance in SCLC1U01CA231776-01 | HANN, CHRISTINE L.MARCHIONNI, LUIGITRAN, PHUOC T. | JOHNS HOPKINS UNIVERSITY, MD | $611,606 | ZCA1 |
| 2018 | Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer1U01CA231844-01 | GOVINDAN, RAMASWAMYGRIFFITH, OBI L.OLIVER, TRUDY GALE | WASHINGTON UNIVERSITY, MO | $589,596 | ZCA1 |
| 2017 | Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer1U01CA213333-01 | GRAY, NATHANAEL SCHIANDERWONG, KWOK KIN | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $703,909 | ZCA1 |
| 2017 | Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC1U01CA213273-01A1 | BYERS, LAUREN AVERETTHEYMACH, JOHN V.SAGE, JULIEN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $615,425 | ZCA1 |
| 2017 | Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer1U01CA213338-01A1 | MINNA, JOHN D. | UT SOUTHWESTERN MEDICAL CENTER, TX | $605,070 | ZCA1 |
| 2017 | Preclinical development of a DLL3-targeted theranostic for small cell lung cancer1U01CA213359-01 | POIRIER, JOHN THOMAS | SLOAN-KETTERING INST CAN RESEARCH, NY | $355,035 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.